PT3390358T - Bis-cloridrato de eravaciclina cristalino - Google Patents

Bis-cloridrato de eravaciclina cristalino

Info

Publication number
PT3390358T
PT3390358T PT177016680T PT17701668T PT3390358T PT 3390358 T PT3390358 T PT 3390358T PT 177016680 T PT177016680 T PT 177016680T PT 17701668 T PT17701668 T PT 17701668T PT 3390358 T PT3390358 T PT 3390358T
Authority
PT
Portugal
Prior art keywords
hydrochloride
eravacycline bis
crystalline eravacycline
crystalline
bis
Prior art date
Application number
PT177016680T
Other languages
English (en)
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=55272232&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT3390358(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of PT3390358T publication Critical patent/PT3390358T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/06Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/65Tetracyclines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
PT177016680T 2016-01-22 2017-01-20 Bis-cloridrato de eravaciclina cristalino PT3390358T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP16152468 2016-01-22

Publications (1)

Publication Number Publication Date
PT3390358T true PT3390358T (pt) 2020-11-09

Family

ID=55272232

Family Applications (1)

Application Number Title Priority Date Filing Date
PT177016680T PT3390358T (pt) 2016-01-22 2017-01-20 Bis-cloridrato de eravaciclina cristalino

Country Status (11)

Country Link
US (2) US10975029B2 (pt)
EP (2) EP3390358B1 (pt)
JP (2) JP7046815B2 (pt)
CN (1) CN108495844B (pt)
AU (1) AU2017208574B2 (pt)
CA (1) CA3011323A1 (pt)
ES (1) ES2834049T3 (pt)
LT (1) LT3390358T (pt)
PT (1) PT3390358T (pt)
WO (1) WO2017125557A1 (pt)
ZA (1) ZA201804685B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6301335B2 (ja) 2012-08-31 2018-03-28 テトラフェース ファーマシューティカルズ,インコーポレイテッド テトラサイクリン化合物
AU2017208574B2 (en) * 2016-01-22 2022-09-22 Sandoz Ag Crystalline eravacycline bis-hydrochloride
EP3529236B1 (en) * 2016-10-19 2024-02-07 Tetraphase Pharmaceuticals, Inc. Crystalline forms of eravacycline

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE758350A (fr) * 1969-12-30 1971-05-03 Pfizer Procede de fabrication des sels mono- et bi-metalliques alcalins de l'alpha-carboxybenzylpenicilline
US4432987A (en) * 1982-04-23 1984-02-21 Pfizer Inc. Crystalline benzenesulfonate salts of sultamicillin
DK0690864T3 (da) * 1993-03-12 2001-09-17 Upjohn Co Krystallinsk ceftiofur på fri syreform
WO2003026572A2 (en) * 2001-09-26 2003-04-03 Merck & Co., Inc. Crystalline forms of ertapenem sodium
SG10201806714PA (en) 2008-08-08 2018-09-27 Tetraphase Pharmaceuticals Inc C7-fluoro substituted tetracycline compounds
US9315451B2 (en) * 2009-05-08 2016-04-19 Tetraphase Pharmaceuticals, Inc. Tetracycline compounds
WO2012021829A1 (en) 2010-08-12 2012-02-16 Tetraphase Pharmaceuticals, Inc. Methods of treating bacterial infections
AU2017208574B2 (en) * 2016-01-22 2022-09-22 Sandoz Ag Crystalline eravacycline bis-hydrochloride
EP3529236B1 (en) 2016-10-19 2024-02-07 Tetraphase Pharmaceuticals, Inc. Crystalline forms of eravacycline

Also Published As

Publication number Publication date
AU2017208574B2 (en) 2022-09-22
CN108495844B (zh) 2022-12-02
CN108495844A (zh) 2018-09-04
ZA201804685B (en) 2019-04-24
JP2019502730A (ja) 2019-01-31
JP2022046485A (ja) 2022-03-23
ES2834049T3 (es) 2021-06-16
EP3390358A1 (en) 2018-10-24
JP7046815B2 (ja) 2022-04-04
EP3390358B1 (en) 2020-09-23
US20210253521A1 (en) 2021-08-19
CA3011323A1 (en) 2017-07-27
US20200199070A1 (en) 2020-06-25
LT3390358T (lt) 2020-11-25
US10975029B2 (en) 2021-04-13
AU2017208574A1 (en) 2018-08-02
WO2017125557A1 (en) 2017-07-27
EP3778567A1 (en) 2021-02-17

Similar Documents

Publication Publication Date Title
IL273730A (en) crystalline forms
GB2546192B (en) Toothbrush orientation system
GB201615128D0 (en) Methods
GB201610162D0 (en) Methods
SG11201707028UA (en) Toothbrush
HK1247125A1 (zh) 結晶化合物
GB201610041D0 (en) Methods
IL262674A (en) crystals
AU366930S (en) Flowerpot
IL265445A (en) crystalline forms
PL3359083T3 (pl) Szczoteczka do zębów
PT3390358T (pt) Bis-cloridrato de eravaciclina cristalino
GB201419174D0 (en) Crystalline forms
HK1255148A1 (zh) 結晶形式
SG11201705074UA (en) Toothbrush
ZA201902553B (en) Crystalline forms
IL261795A (en) Crystalline form
GB201715010D0 (en) Crystalline forms
GB201708856D0 (en) Seletalisib crystalline forms
GB201611425D0 (en) Methods
GB201604759D0 (en) Crystalline compounds
GB201610038D0 (en) Methods
GB201607817D0 (en) Methods
GB201603559D0 (en) Methods
GB201601868D0 (en) Methods